Biopharma IPOs From the First Half of 2024
Pictured: Pair of hands framing graph of upward-trending numbers/Nicole Bean for BioSpace At the end of 2023, PwC predicted a “gradual uptick” in IPOs, with the market expected to favor those companies with “strong clinical data.” Roel van den Akker, …